HOOKIPA Pharma Inc. Banner Image

HOOKIPA Pharma Inc.

  • Ticker HOOK
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
HOOKIPA Pharma Inc. Logo Image
  • 51-200 Employees
  • Based in Vienna, Austria
HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical stage biopharmaceutical company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that reprograms the body’s immune system. HOOKIPA’s proprietary arenavirus-based technologies, non-replicating (VaxWave®) and replicating (TheraT®), induce robust antigen-specificMore CD8+ T cells and pathogen-neutralizing antibodies. HOOKIPA’s “off-the-shelf” viral vectors target antigen presenting cells in vivo to activate the immune system. Both technologies enable repeat administration to augment and refresh immune responses. As a monotherapy, their replicating arenavirus technology has the potential to induce CD8+ T cell response levels previously not achieved by other immuno-therapy approaches.
HOOKIPA Pharma Inc.

Most Recent Annual Report

HOOKIPA Pharma Inc.
MOST RECENT 2021 Annual Report and Form 10K

Older/Archived Annual Reports